反应条件
1: N-pentanoyl-N-[[2'-[N-(triphenylmethyl)tetrazol-5-yl]-1,1'-biphenyl-4-yl]methyl]amine With 2,6-dimethylpyridine; oxalyl dichloride in toluene T=0°C; 1 h; 2: ethyl 1-amino-1-cyclopentanecarboxylate in toluene T=0 - 20°C; 1 h;
参考文献
TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC.
Patent: WO2004/72064 A1, 2004 ;
Location in patent: Page 15 ;